Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil versus fentanyl infusion in mechanically ventilated ICU patients
ACTRN12620000719932Phase 2Completed
- Sponsor
- Arvind Rajamani
- Start
- Jun 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in respiratory failure, Airway Obstruction (AO), sepsis and 2 more comparing Remifentanil infusion with Fentanyl infusion (2 arms). Primary endpoints: Number of patients recruited and Compliance of use of the study drug >90%. Started Jun 2020; status: completed.
02
Drugs
remifentanilfentanyl
03
Conditions
respiratory failureAirway Obstruction (AO)sepsisseizuretraumatic brain injury (TBI)
Beyond the preview
Go deeper on ACTRN12620000719932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000719932.